Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>Daiwa Rates WUXI BIO as Buy; WUXI XDC Proposes Takeover Bid for BIODLINK-B
Recommend 2 Positive 5 Negative 4 |
||||
|
||||
|
WUXI BIO (02269.HK) and WUXI XDC (02268.HK) announced a takeover bid of up to around HKD2.8 billion to acquire at least 60% of BIODLINK-B (01875.HK)'s shares, according to Daiwa's research report. BIODLINK-B is expected to maintain its listed status after the acquisition. In WUXI XDC's estimate, this acquisition will help expand its business and gain additional operational production capacity in China, further enriching its project portfolio, enlarging its customer base, and consolidating its leading market position in the ADC contract development and manufacturing organization sector. Daiwa is currently rating WUXI BIO as Buy. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
